Equivalent 10-Year Outcomes After Implantation of Autologous Bone Marrow–Derived Mesenchymal Stem Cells Versus Autologous Chondrocyte Implantation for Chondral Defects of the Knee

• Published in: The American journal of sports medicine Vol. 47; no. 12; pp. 2881 - 2887
• Main Authors: Teo, Alex Quok An, Wong, Keng Lin, Shen, Liang, Lim, Jia Ying, Toh, Wei Seong, Lee, Eng Hin, Hui, James Hoi Po
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01-10-2019; Sage Publications Ltd
• Subjects: Adult; Bone marrow; Bone Marrow Cells; Cartilage, Articular - injuries; Cartilage, Articular - surgery; Chondrocytes - transplantation; Clinical outcomes; Female; Follow-Up Studies; Humans; Knee Injuries - surgery; Lysholm Knee Score; Male; Mesenchymal Stem Cell Transplantation; Middle Aged; Orthopedic Procedures - methods; Patient Reported Outcome Measures; Patients; Sports medicine; Stem cells; Transplantation, Autologous; Transplants & implants; articular cartilage resurfacing; bone marrow–derived stem cells; knee articular cartilage; autologous chondrocyte implantation
• ISSN: 0363-5465; 1552-3365
• DOI: 10.1177/0363546519867933

Background:
The use of bone marrow–derived mesenchymal stem cells (BMSCs) in cartilage repair procedures circumvents some of the limitations of autologous chondrocyte implantation (ACI), but long-term outcomes for this newer procedure are lacking. The authors previously reported comparable outcomes for the 2 procedures at 2-year follow-up.
Purpose/Hypothesis:
The purpose was to compare the long-term clinical outcomes of ACI versus BMSCs. It was hypothesized that there would be no significant difference between the groups in terms of patient-reported outcome scores and safety outcomes at 10-year follow-up.
Study Design:
Cohort study; Level of evidence, 2.
Methods:
Seventy-two patients who underwent either ACI or BMSC implantation—matched in terms of age and lesion site— were followed up to a median of at least 10 years. Patients were assessed with the 36-item Short Form Health Survey (SF-36), the International Knee Documentation Committee knee evaluation form, the Lysholm Knee Score, and the Tegner Activity Scale. In addition, information was obtained regarding any additional surgical procedures as well as safety data, with particular attention to infection and tumor formation.
Results:
There was an improvement in all patient-reported outcomes scores apart from the Mental Component Summary of the SF-36 after cartilage repair surgery. There was no significant difference in any of the patient-reported outcomes between cohorts at any time point. Six and 5 patients in the ACI and BMSC groups, respectively, underwent subsequent surgical procedures, including 1 total knee replacement in the BMSC group. None of the patients in either group developed any deep infection or tumor within the follow-up period.
Conclusion:
BMSC implantation used for the treatment of chondral defects of the knee appears to result in equivalent clinical outcomes to first-generation ACI at up to 10 years, with no apparent increased tumor formation risk.